BR112012029396A2 - métodos relativos a um micoplasma atenuado. - Google Patents
métodos relativos a um micoplasma atenuado.Info
- Publication number
- BR112012029396A2 BR112012029396A2 BR112012029396A BR112012029396A BR112012029396A2 BR 112012029396 A2 BR112012029396 A2 BR 112012029396A2 BR 112012029396 A BR112012029396 A BR 112012029396A BR 112012029396 A BR112012029396 A BR 112012029396A BR 112012029396 A2 BR112012029396 A2 BR 112012029396A2
- Authority
- BR
- Brazil
- Prior art keywords
- bacterium
- mycoplasma
- methods related
- attenuated mycoplasma
- attenuated
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
- C12Q1/02—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving viable microorganisms
- C12Q1/04—Determining presence or kind of microorganism; Use of selective media for testing antibiotics or bacteriocides; Compositions containing a chemical indicator therefor
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N1/00—Microorganisms, e.g. protozoa; Compositions thereof; Processes of propagating, maintaining or preserving microorganisms or compositions thereof; Processes of preparing or isolating a composition containing a microorganism; Culture media therefor
- C12N1/36—Adaptation or attenuation of cells
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/02—Bacterial antigens
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/02—Bacterial antigens
- A61K39/0241—Mollicutes, e.g. Mycoplasma, Erysipelothrix
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/04—Antibacterial agents
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/195—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria
- C07K14/30—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria from Mycoplasmatales, e.g. Pleuropneumonia-like organisms [PPLO]
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N1/00—Microorganisms, e.g. protozoa; Compositions thereof; Processes of propagating, maintaining or preserving microorganisms or compositions thereof; Processes of preparing or isolating a composition containing a microorganism; Culture media therefor
- C12N1/20—Bacteria; Culture media therefor
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
- C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
- C12Q1/6876—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes
- C12Q1/6888—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for detection or identification of organisms
- C12Q1/689—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for detection or identification of organisms for bacteria
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/51—Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
- A61K2039/52—Bacterial cells; Fungal cells; Protozoal cells
- A61K2039/522—Bacterial cells; Fungal cells; Protozoal cells avirulent or attenuated
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q2600/00—Oligonucleotides characterized by their use
- C12Q2600/156—Polymorphic or mutational markers
Landscapes
- Chemical & Material Sciences (AREA)
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Organic Chemistry (AREA)
- Engineering & Computer Science (AREA)
- Zoology (AREA)
- Wood Science & Technology (AREA)
- Genetics & Genomics (AREA)
- General Health & Medical Sciences (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Biotechnology (AREA)
- Microbiology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Medicinal Chemistry (AREA)
- Biochemistry (AREA)
- Analytical Chemistry (AREA)
- General Engineering & Computer Science (AREA)
- Immunology (AREA)
- Biophysics (AREA)
- Molecular Biology (AREA)
- Tropical Medicine & Parasitology (AREA)
- Virology (AREA)
- Biomedical Technology (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- Cell Biology (AREA)
- Physics & Mathematics (AREA)
- Mycology (AREA)
- Epidemiology (AREA)
- Pulmonology (AREA)
- Gastroenterology & Hepatology (AREA)
- Communicable Diseases (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Oncology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Toxicology (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
Abstract
métodos relativos a um micoplasma atenuado - a presente invenção refere-se a um método para identificar ou gerar uma bactéria de mycoplasma atenuado em que a bactéria compreende uma mutação em pelo menos um gene como listado e uso da bactéria em uma vacina para suscitar imunidade protetora contra mycoplasma ou para detectar infecção através da dita bactéria.
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
AU2010902198A AU2010902198A0 (en) | 2010-05-19 | Methods relating to an attenuated mycoplasma | |
PCT/AU2011/000584 WO2011143706A1 (en) | 2010-05-19 | 2011-05-19 | Methods relating to an attenuated mycoplasma |
Publications (1)
Publication Number | Publication Date |
---|---|
BR112012029396A2 true BR112012029396A2 (pt) | 2019-09-24 |
Family
ID=44991084
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
BR112012029396A BR112012029396A2 (pt) | 2010-05-19 | 2011-05-19 | métodos relativos a um micoplasma atenuado. |
Country Status (11)
Country | Link |
---|---|
US (1) | US9260691B2 (pt) |
EP (1) | EP2571980A4 (pt) |
JP (1) | JP2013526866A (pt) |
KR (1) | KR20130086154A (pt) |
CN (1) | CN102985530A (pt) |
AU (1) | AU2011256137B2 (pt) |
BR (1) | BR112012029396A2 (pt) |
CA (1) | CA2799732A1 (pt) |
EA (1) | EA201291175A1 (pt) |
MX (1) | MX2012013409A (pt) |
WO (1) | WO2011143706A1 (pt) |
Families Citing this family (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
EP2684959A1 (en) * | 2012-07-10 | 2014-01-15 | Laboratorios Hipra, S.A. | Vectors for transforming Mycoplasma hyopneumoniae, transformed M.hyopneumoniae strains, and use thereof |
CN114940955B (zh) * | 2022-05-10 | 2023-08-11 | 兆丰华生物科技(南京)有限公司 | 一种鸡毒支原体弱毒疫苗株及其应用 |
CN117690485B (zh) * | 2024-02-04 | 2024-05-28 | 北京诺禾致源科技股份有限公司 | 用于寄生虫鉴定的基因组的处理方法和处理装置 |
Family Cites Families (8)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
DK1117435T3 (da) | 1998-09-30 | 2008-03-17 | Wyeth Corp | Muteret cholera-holotoxin som adjuvans |
US6585981B1 (en) | 2000-07-27 | 2003-07-01 | Regents Of The University Of Minnesota | Temperature-sensitive live vaccine for Mycoplasma hyopneumoniae |
DK2007419T3 (da) | 2006-04-10 | 2012-03-19 | Intervet Int Bv | Vaccine mod mycoplasma PRRSV |
US20090068231A1 (en) | 2007-09-11 | 2009-03-12 | Wyeth | Live attenuated mycoplasma strains |
CL2008002675A1 (es) | 2007-09-11 | 2008-11-07 | Wyeth Corp | Bacteria de mycoplasma gallisepticum atenuada; composicion de vacuna que la comprende; método de vacunación; y método de identificación de clones de mycoplasma gallisepticum atenuados. |
MX2010005014A (es) * | 2007-11-06 | 2010-06-30 | Wyeth Llc | Vacuna viva avirulenta de mycoplasma hyopneumoniae con adyuvante. |
JP5753098B2 (ja) | 2009-02-20 | 2015-07-22 | オーストラリアン ポールトリー シーアールシー ピーティーワイ リミテッド | 弱毒生ワクチン |
MX2011012362A (es) | 2009-05-19 | 2012-04-19 | Bioproperties Pty Ltd | Cepa de vacuna de mycoplasma hyopneumoniae sensible a la temperatura y usoz de la misma. |
-
2011
- 2011-05-19 EP EP11782772.5A patent/EP2571980A4/en not_active Withdrawn
- 2011-05-19 US US13/697,714 patent/US9260691B2/en not_active Expired - Fee Related
- 2011-05-19 WO PCT/AU2011/000584 patent/WO2011143706A1/en active Application Filing
- 2011-05-19 AU AU2011256137A patent/AU2011256137B2/en not_active Ceased
- 2011-05-19 CN CN2011800248228A patent/CN102985530A/zh active Pending
- 2011-05-19 CA CA2799732A patent/CA2799732A1/en not_active Abandoned
- 2011-05-19 EA EA201291175A patent/EA201291175A1/ru unknown
- 2011-05-19 JP JP2013510450A patent/JP2013526866A/ja not_active Ceased
- 2011-05-19 KR KR1020127033017A patent/KR20130086154A/ko not_active Application Discontinuation
- 2011-05-19 MX MX2012013409A patent/MX2012013409A/es unknown
- 2011-05-19 BR BR112012029396A patent/BR112012029396A2/pt not_active IP Right Cessation
Also Published As
Publication number | Publication date |
---|---|
EP2571980A1 (en) | 2013-03-27 |
WO2011143706A1 (en) | 2011-11-24 |
JP2013526866A (ja) | 2013-06-27 |
MX2012013409A (es) | 2013-03-07 |
AU2011256137B2 (en) | 2015-01-22 |
US20130243819A1 (en) | 2013-09-19 |
US9260691B2 (en) | 2016-02-16 |
CA2799732A1 (en) | 2011-11-24 |
KR20130086154A (ko) | 2013-07-31 |
EP2571980A4 (en) | 2014-02-26 |
CN102985530A (zh) | 2013-03-20 |
AU2011256137A1 (en) | 2012-11-29 |
EA201291175A1 (ru) | 2013-06-28 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
BR112014032636A2 (pt) | Vacinas atenuadas de streptococcus suis e métodos de produção e usos das mesmas | |
BR112018077266A2 (pt) | composições compreendendo cepas bacterianas | |
CL2011002639A1 (es) | Cepa bacteriana de mycoplasma bovis atenuada avirulenta; composicion inmunogenica que la comprende; y uso para fabricar un medicamento para infecciones producidas por m. bovis. | |
BR112016003127A2 (pt) | composições e métodos para modular rna | |
BR112012004698A2 (pt) | métodos de redução de atividade virucida em composições de pcv-2 e composições de pcv-2 com uma imonugenicidade aprimorada. | |
BR112012022755A2 (pt) | composição com bactérias probióticas para uso no tratamento de distúrbios imunológicos | |
BR112014026740A8 (pt) | anticorpo, composição, método para fornecer um anticorpo com adcc realçada, e, uso de um anticorpo | |
BR112013005329A2 (pt) | variantes não lipidadas de antígenos orf2086 de neisseria meningitidis | |
BRPI0815008B8 (pt) | vacinas multiméricas com múltiplos epítopos contra influenza | |
BR112012027747A2 (pt) | método e composição imunogênica para tratamento de neoplásia | |
BR112014013876A2 (pt) | vacina à base de toxina de clostridium difficile | |
CO6751260A2 (es) | Vacunas basadas en omv contra infecciones por burkholderia | |
BR112012020628A2 (pt) | fotoiniciador de éter polialquílico, uso de um fotoiniciador de éter polialquílico, método para curar uma composição de matriz, e, composição de matriz | |
BR112014018732A8 (pt) | Composições imunogênicas contra campylobacter e usos das mesmas | |
BR112015021523A8 (pt) | composição de uma vacina contra a tosse convulsa acelular, e, usos da composição e de antígenos da bordetella pertussis | |
CL2008002675A1 (es) | Bacteria de mycoplasma gallisepticum atenuada; composicion de vacuna que la comprende; método de vacunación; y método de identificación de clones de mycoplasma gallisepticum atenuados. | |
BR112015021210A2 (pt) | métodos e composições para o direcionamento de rna polimerases e biogênese de rna não codificante para locais específicos | |
MX2010000864A (es) | Vacuna de celulas enteras estafilococcicas inactivadas. | |
CO6361948A2 (es) | Uso de antigeno de mycoplasma bovis | |
BR112017004197A2 (pt) | composições de vacina contra doenças do vírus da dengue | |
BR112015022582A2 (pt) | molécula de ácido nucleico, plasmídeo, vacina, e, uso de um plasmídeo | |
BR112012008150A2 (pt) | sistema e método para verificar a idade de um usuário de internet | |
CL2012002902A1 (es) | Cepas de bacteriofagos especifica contra bacterias pertenecientes al genero vibrio para la profilaxis y terapia de vibrio anguillarum; y composicion antibacteriana que comprende dicha cepas. | |
BR112017000022A2 (pt) | nanoparticulas terapêuticas direcionadas a alvo e métodos de produção e uso dessas partículas | |
BR112012029396A2 (pt) | métodos relativos a um micoplasma atenuado. |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
B08F | Application fees: application dismissed [chapter 8.6 patent gazette] | ||
B08K | Patent lapsed as no evidence of payment of the annual fee has been furnished to inpi [chapter 8.11 patent gazette] |
Free format text: EM VIRTUDE DO ARQUIVAMENTO PUBLICADO NA RPI 2543 DE 01-10-2019 E CONSIDERANDO AUSENCIA DE MANIFESTACAO DENTRO DOS PRAZOS LEGAIS, INFORMO QUE CABE SER MANTIDO O ARQUIVAMENTO DO PEDIDO DE PATENTE, CONFORME O DISPOSTO NO ARTIGO 12, DA RESOLUCAO 113/2013. |